Does extreme , progressive isovolemic hemodilution with 5 % human albumin , PentaLyte , or Hextend cause hepatic ischemia or histologic injury in rabbits?
Isovolemic hemodilution (approximately 5% hematocrit) with albumin, pentastarch, or hetastarch solutions does not result in significant hepatic ischemia or injury assessed by histology.
The prototype device closely follows arterial pressure changes in children. However, in a considerable number of attempts, obtaining a signal was time-consuming or unsuccessful. This technique seems promising but requires further technical development.